Pune, India, September, 2022/press release/- Market Research Future Published a Half-Cooked Research Report on Microarray Analysis Market Research Report.
Market Synopsis
The Microarray Analysis Market is expected to reach USD 4,940.22 million at 8.20% CAGR during the forecast period 2022-2030
The global microarray analysis market is estimated to expand at a remarkable CAGR during the forecast period (2022-2030) owing to the increasing prevalence of genetic disorders, asserts Market Research Future (MRFR). Microarray analysis is a molecular biology technique which uses microchips with attached DNA segments used for gene expression analysis on a large scale. Microarray analysis is used in several experiments such as translation profiling, biomarker profiling, epigenetics, genotyping, pathway identification mutations, and gene expression profiling. It enables scientists analyze several genes at the same time with accurate results.
Drivers and Constraints Impacting the Market
With the growing focus on drug discovery and development, increasing prevalence of genetic disorders coupled with growing demand for personalized medicines, the global market is likely to trigger during the forecast period. Microarray analysis is used to understand gene patterns in tumors and also detect cancer biomarker. Thus, the growing prevalence of cancer along with rising investment for cancer research is estimated to fuel the market growth.
On the flip side, high cost associated with diagnosis, inaccurate results, and contamination is estimated to inhibit the market growth in the coming years.
Global Microarray Analysis Market: Segmental Analysis
The global microarray analysis market has been segmented on the basis of application, type, product type, end-user, and region.
By mode of type, the global microarray analysis market has been segmented into tissue microarrays, protein microarrays, glycan arrays, DNA microarrays, phenotype microarrays, chemical compound microarrays, and cellular microarrays. Among these, the segment for DNA microarrays is estimated to account for the largest market share owing to its extensive use in several applications such as diagnostic centers, pharmaceuticals, academic and research institutes, ambulatory care centers, hospitals and clinics, and biotechnology.
By mode of application, the market has been segmented into research, disease diagnosis, genomics, genotyping, proteomics, forensic analysis, drug discovery, and toxicological research. Among these, the drug discovery segment is predicted to expand at the highest CAGR during the assessment period.
By mode of product type, the global market has been segmented into DNA chips, reagents, primers, instruments, reagent kits, and buffers. Among these, the instrument segment has been sub-segmented into hybridization oven, Multi-Channel (MC) instrument, scanner, centrifuge, slide imprinters, target preparation instrument, and others.
By mode of end-users, the global market has been segmented into pharmaceuticals, academic and research institutes, biotechnology, diagnostic centers, hospitals and clinics, ambulatory care centers, and others.
Regional Insights
Geographically, the global market span across regions namely, Europe, America, Asia Pacific, and the Middle East and Africa.
Among all the regions, the American region is estimated to dominate the global market owing to the higher adoption rate of advanced technology for diagnosis, high investment in research and development, and rising awareness among the people for better diagnostics.
The European region is presumed to hold the second largest position in the global market owing to the increasing focus on personalized medicine, drug discovery, and targeted therapy.
The Asian Pacific market is estimated to register a substantial growth rate due to increasing prevalence of genetic disorders, government initiatives, and increasing awareness among the people. Meanwhile, the Middle East and Africa are estimated to hold the least share owing to the low funding in health and medical research.
Industry News
A team of researchers at Lund University, Herlev Hospital, Knight Cancer Center, and Immunovia AB, has developed a blood test that can detect pancreatic cancer at a very early stage. The blood test has been developed on an antibody microarray that comprises hundreds of recombinant antibody fragments.
Competitive Dashboard
The major players operating the global market are Discerna, Illumnia Inc., NextGen Sciences PLC, Roche NimbleGen, Thermo Fisher Scientific, Luminex Corporation, Agilent Technologies Inc., ProteoGenix, Biomerieux SA, Applied Microarrays, Gyros AB, Affymetrix Inc., Sequenom Inc., and others
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Microarray Analysis Market Research Report
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Base Year | 2022 |
Companies Covered | 15 |
Pages | 115 |
Certified Global Research Member
![Isomar fd.webp](/assets/new_images/isomar-fd.webp-639e56ab480ebeefc64ce7663b3567c1213cbde51578df3a8dd3cda5e0bdc253.webp)
![Wcrc 57.webp](/assets/new_images/WCRC-57.webp-40ea92ba8885facb35c7d4d5d2337b078d89cd17a5ac5264d4de6398c023d350.webp)
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.